SCHEMBL2257958

SCHEMBL2257958

C=C1C=C(O)[C@]23C[C@]24CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@]2(C)[C@@H]4CC[C@H]3C1(C)C

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ EBP Q15125 8/20 0.45
▸ ACLY P53396 2/20 0.38
▸ ACACA Q13085 2/20 0.38
▸ HSD11B1 P28845 2/20 0.38
▸ HMGCR P04035 2/20 0.36
▸ CDC25A P30304 4/20 0.35
▸ CDC25B P30305 4/20 0.35
▸ NPC1L1 Q9UHC9 1/20 0.34
▸ PRKAG1 P54619 1/20 0.34
▸ PRKAA2 P54646 1/20 0.34
▸ PRKAB1 Q9Y478 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159792 0.82 EBP (0.47) EBPACLYACACAHSD11B1HMGCR
SCHEMBL6341662 0.78 HSD11B1 (0.45) EBPACLYACACAHSD11B1HMGCR
SCHEMBL22099803 0.77 EBP (0.47) EBPACLYACACAHSD11B1HMGCR
SCHEMBL377472 0.73 ACLY (0.38) EBPACLYACACAHSD11B1PRKAG1
SCHEMBL8148952 0.72 EBP (0.48) EBPACLYACACAHSD11B1HMGCR
SCHEMBL10635071 0.72 HSD11B1 (0.40) EBPACLYACACAHSD11B1HMGCR
Cycloartanol SCHEMBL12152356 0.71 ACLY (0.67) EBPACLYACACAHSD11B1HMGCR
Cycloartanol SCHEMBL1881616 0.71 ACLY (0.67) EBPACLYACACAHSD11B1HMGCR
Cycloartanol SCHEMBL13324286 0.71 ACLY (0.67) EBPACLYACACAHSD11B1HMGCR
Cycloartanol SCHEMBL1881613 0.71 ACLY (0.67) EBPACLYACACAHSD11B1HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060233862-A1 Process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof KARLSHAMNS AB (SE) 2006-10-19 — — US claimed
US-20040047971-A1 Process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof KARLSHAMNS AB (SE) 2004-03-11 — — US claimed
EP-1349909-A1 A PROCESS FOR THE PREPARATION OF A FAT COMPOSITION CONTAINING STEROL ESTERS A PRODUCT OBTAINED BY SAID PROCESS AND THE USE THEREOF Karlshamns AB (SE) 2003-10-08 — — EP claimed
WO-2002055639-A1 A PROCESS FOR THE PREPARATION OF A FAT COMPOSITION CONTAINING STEROL ESTERS A PRODUCT OBTAINED BY SAID PROCESS AND THE USE THEREOF KARLSHAMNS AB (SE) 2002-07-18 — — WO claimed
EP-2016147-B1 WATER-SOLUBLE ROSIN ACID ESTERS ARIZONA CHEM (US) 2017-07-26 — — EP disclosed
US-7994106-B2 Water soluble rosin acid esters ARIZONA CHEMICAL COMPANY, LLC (US) 2011-08-09 — — US disclosed
US-7635798-B2 Nucleic acid compositions conferring altered metabolic characteristics DOW AGROSCIENCES, LLC (US) 2009-12-22 — — US disclosed
EP-2016147-A1 WATER-SOLUBLE ROSIN ACID ESTERS Arizona Chemical Company (US) 2009-01-21 — — EP disclosed
US-20080020957-A1 WATER SOLUBLE ROSIN ACID ESTERS KRATON CHEMICAL, LLC 2008-01-24 — — US disclosed
WO-2007134138-A1 WATER-SOLUBLE ROSIN ACID ESTERS ARIZONA CHEMICAL COMPANY (US) 2007-11-22 — — WO disclosed
US-20070256594-A1 Release Agents Containing Saponified Fatty and Rosin Acids or Derivatives Thereof ARIZONA CHEMICAL COMPANY LLC 2007-11-08 — — US disclosed
CN-101010127-A Antifoam compositions containing dispersions of hydrophobic particles ARIZONA CHEM (US) 2007-08-01 — — CN disclosed
US-20040047971-A1 Process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof KARLSHAMNS AB (SE) 2004-03-11 — — US disclosed
EP-1349909-A1 A PROCESS FOR THE PREPARATION OF A FAT COMPOSITION CONTAINING STEROL ESTERS A PRODUCT OBTAINED BY SAID PROCESS AND THE USE THEREOF Karlshamns AB (SE) 2003-10-08 — — EP disclosed
US-6590113-B1 Contacting first oil containing antioxidant compounds selected from tocopherols, tocotrienols and/or sterols with effective amount of compound under conditions to esterify at least about 50% of antioxidants to produce second oil containing esters SLEETER RONALD T (US) 2003-07-08 — — US disclosed
WO-2003020936-A1 NUCLEIC ACID COMPOSITIONS CONFERRING ALTERED METABOLIC CHARACTERISTICS THE DOW CHEMICAL COMPANY (US) 2003-03-13 — — WO disclosed
US-6462210-B1 THROUGH THIS PROCEDURE FRACTIONS THAT ESSENTIALLY CONTAIN FREE STEROLS, FATTY ALCOHOLS, STEROL ESTERS AND FATTY ALCOHOL ESTERS RESPECTIVELY ARE SEPARATED HARTING, S.A. (CL) 2002-10-08 — — US disclosed
WO-2002055639-A1 A PROCESS FOR THE PREPARATION OF A FAT COMPOSITION CONTAINING STEROL ESTERS A PRODUCT OBTAINED BY SAID PROCESS AND THE USE THEREOF KARLSHAMNS AB (SE) 2002-07-18 — — WO disclosed
US-6297353-B1 RECOVERING NEUTRAL PARTICLES FROM SOLUTION; NEUTRALIZE PREFERENTIAL PITCH, DEHYDRATE NEUTRALIZED SOLUTION CURRENT, FEED DEHYDRATED CURRENT TO CHROMATAGRAPHY COLUMN, DISTILL CURRENT, RECOVER DISTILLATE CURRENT, RECOVER RESIDUE CURRENT HARTING, S.A. (CL) 2001-10-02 — — US disclosed
EP-0952208-A2 High efficiency method for obtaining an unsaponifiable fraction from black-liquor soaps or crude tall oil Härting S.A. (CL) 1999-10-27 — — EP disclosed
Send feedback